Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

University of Toronto

$914,175.00

Adherens junction dynamics and function in epithelial tissue morphogenesis

EF 2022-23

Résumé
The main damage done by most cancer cells results from invasion and metastasis. For this to occur, cancer cells have to leave the primary tumor and move to other tissues. Cells in our body do typically not leave their home tissue when healthy; in order for that to happen cancer cells have to change the properties of the glue that cells use to stick to their neighbors. Dr Tepass' laboratory identifies and analyzes the components of this molecular glue that mediates adhesion between cells. The glue molecule cadherin was shown to be broadly relevant for normal tissue development and cancer progression. Cadherin function critically depends on several other molecules including alpha-Catenin and other proteins that together form the adherens junction. These cellular junctions are engaged in maintaining normal tissue shape of epithelia, and in preventing cells from leaving the epithelium to form metastases. This is of particular significance as most forms of cancer called carcinomas derive from epithelial cells. We use the fruit fly Drosophila as a stand-in for humans to investigate how adherens junction proteins govern cell behaviour. The main work in the Tepass laboratory will focus on alpha-Catenin and other proteins that link transmembrane cadherin to the cytoskeleton, an interaction that is essential for cadherin function and currently only poorly understood. Insights into how adherens junctions normally operate is expected to inform us about the role of these factors in cancer and other pathologies, and ultimately will help develop better tools for disease diagnosis and treatment.
Programme
Project Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
469118
Name
Tepass Ulrich
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Cell and Developmental Physiology
Projecttitle
Adherens junction dynamics and function in epithelial tissue morphogenesis
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$914,175
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Adherens Junction; Cadherin; Cancer; Catenin; Cell Adhesion; Cell Polarity; Cell Shape; Cytoskeleton; Epithelia; Morphogenesis
Abstract
The main damage done by most cancer cells results from invasion and metastasis. For this to occur, cancer cells have to leave the primary tumor and move to other tissues. Cells in our body do typically not leave their home tissue when healthy; in order for that to happen cancer cells have to change the properties of the glue that cells use to stick to their neighbors. Dr Tepass' laboratory identifies and analyzes the components of this molecular glue that mediates adhesion between cells. The glue molecule cadherin was shown to be broadly relevant for normal tissue development and cancer progression. Cadherin function critically depends on several other molecules including alpha-Catenin and other proteins that together form the adherens junction. These cellular junctions are engaged in maintaining normal tissue shape of epithelia, and in preventing cells from leaving the epithelium to form metastases. This is of particular significance as most forms of cancer called carcinomas derive from epithelial cells. We use the fruit fly Drosophila as a stand-in for humans to investigate how adherens junction proteins govern cell behaviour. The main work in the Tepass laboratory will focus on alpha-Catenin and other proteins that link transmembrane cadherin to the cytoskeleton, an interaction that is essential for cadherin function and currently only poorly understood. Insights into how adherens junctions normally operate is expected to inform us about the role of these factors in cancer and other pathologies, and ultimately will help develop better tools for disease diagnosis and treatment.
Competitiondate
202209
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Tepass, Ulrich
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $914,175~ $0~